SCHEMBL91093

SCHEMBL91093

CP(O)OCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17210714 0.79 DNM1 (0.38)
SCHEMBL10050128 0.75
SCHEMBL11126725 0.75
SCHEMBL29173088 0.73
SCHEMBL9750691 0.73
SCHEMBL21123053 0.72
SCHEMBL17514073 0.71
SCHEMBL16588372 0.71
SCHEMBL19480772 0.67
SCHEMBL29314837 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053618-A1 RADIATION SENSITIVE LIPOSOMES VARIAN MEDICAL SYSTEMS, INC. (US) 2013-02-28 US disclosed
US-8128942-B2 Anti-sepsis conjugate vaccine ENDOBIOLOGICS, INCORPORATED (US) 2012-03-06 US disclosed
US-20110027307-A1 ANTI-SEPSIS CONJUGATE VACCINE ENDOBIOLOGICS, INCORPORATED (US) 2011-02-03 US disclosed
US-20090042973-A1 Inhibitors of aspartyl protease VERTEX PHARMACEUTICALS INCORPORATED 2009-02-12 US disclosed
US-7442718-B2 Inhibitors of aspartyl protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-10-28 US disclosed